9 Myths and Facts About Clinical Trials for Alzheimer’s Disease

Clinical trials are essential to help improve treatments, therapies and diagnostic techniques for Alzheimer's disease and hopefully, one day find a cure. However, there's a lot of misinformation out there so we've put together a list of myths and facts about clinical trials for Alzheimer's disease based on information from the Alzheimer's Association. Myth: There are already lots of participants for clinical trials, so I won't be needed. Fact: Clinical research is ongoing, so there will always be a need for participants. There are currently more than 250 clinical trials that are recruiting people with dementia, those who are at an elevated risk of developing dementia, and also caregivers of people with dementia and Alzheimer's. Myth: I am at too advanced a stage of Alzheimer's to participate in a clinical trial. Fact: There are clinical trials for all stages of the disease, including the very late stages. Your participation could help thousands of others. Myth: Participating in a clinical trial could be dangerous as they use unproven medications and treatments. Fact: While there is an element of risk with any clinical trial, there are many safeguards put in place to protect those who participate; participants are regularly monitored and can withdraw at any time. However, all drugs and treatments have potential side effects, some of which could be life-threatening. MORE: Schizophrenia treatment seen to erase agitation in Alzheimer's patients in Phase 3 clinical trial.  Myth: I won't re
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *